Interview with Harshal Shah, Head of Oncology Drug Delivery at Cambridge Consultants

Thanks to the ongoing advancements in standards of care and gradual improvements in more targeted therapeutics, some argue that cancer is slowly turning into a chronic disease, and with it bringing about a host of new challenges for oncology care. These challenges are also opening up a variety of new opportunities for technical innovations that wou (Read more...)

Full Story →